Treat acute coronary syndromes off-label, NICE suggests
This article was originally published in Scrip
Executive Summary
The early management of unstable angina and non-ST-segment-elevation myocardial infarction (NSTEMI) may sometimes involve the use of drugs outside their UK marketing authorisations, a draft clinical guideline from the National Institute for health and Clinical Excellence proposes.